Wed 25 March 2026
Landmark JPPR issue highlights medication safety in 60th year
Advanced Pharmacy Australia (AdPha) has released a special issue of its flagship Journal of Pharmacy Practice and Research (JPPR), dedicated to medication safety and formally releasing the Advanced Pharmacy Australia Medication Safety Standards, while marking the Journal’s 60th anniversary.
Guest edited by Dr Nazanin Falconer FANZCAP (Research), Co-Chair of AdPha’s Research Leadership Committee and Senior Lecturer at The University of Queensland, with support from Editor-in-Chief Professor Michael Dooley, the special issue brings together leading perspectives on one of healthcare’s most critical priorities, including:
- An editorial by Dr Nazanin Falconer FANZCAP (Research), Dr Elizabeth McCourt FAdPha and Professor Michael Barras FAdPha FANZCAP (Lead&Mgmt, Research)
- A contribution from AdPha’s Medication Safety Working Group on the development of the Medication Safety Standards
- Insights from Michael Bakker FANZCAP (Informtcs) on the role of informatics and technology in transforming medication safety
- Perspectives from Steven Waller, former consultant to the Australian Commission on Safety and Quality in Health Care, on Australia’s response to the WHO Global Patient Safety Challenge: Medication Without Harm
Dr Falconer says the issue reinforces the importance of medication safety in everyday practice.
‘Medication safety is everyone’s business, every day.
‘Special issues like this shine a light on the research and patient safety initiatives that are making a real difference. They remind us that improving medication safety is part of our mandate as clinical pharmacists and highlight the impact this work has on patient outcomes.
‘It’s also an opportunity to inspire pharmacists to engage in research, because this work truly matters and drives our profession forward.’
Dr Falconer also highlighted the value of the collaborative editorial process especially as a first-time acting editor.
‘I’ve loved the opportunity and learnt so much working alongside Professor Michael Dooley, Professor Michael Barras and the JPPR team.
‘Experiences like this are incredibly valuable, particularly for early- and mid-career researchers looking to build skills, contribute to advancing practice, and make their mark on the profession.’
As part of its ongoing commitment to advancing research and practice, AdPha has announced a second special issue of JPPR will publish in 2027, with expressions of interest sought from all national Specialty Practice Leadership Committees, comprising elected leaders from the membership across 27 pharmacy specialties.
This milestone edition reinforces AdPha’s leadership in medication safety in Australian pharmacy, while celebrating six decades of JPPR’s contribution to evidence-based pharmacy practice.